CD133-TARGETED NATURAL KILLER CELL THERAPY FOR AGGRESSIVE PROSTATE CANCER

$920,007FY2019Department of the ArmyDOD

University Of Wisconsin System, Madison WI

Investigators

View source on USAspending →